Skip to main content
Erschienen in: Surgery Today 7/2014

01.07.2014 | Original Article

Diagnostic value of 18F-FDG PET/CT for lymph node metastasis of esophageal squamous cell carcinoma

verfasst von: Hiroyuki Yamada, Masao Hosokawa, Kazuo Itoh, Toshinao Takenouchi, Yoshihiro Kinoshita, Tomohiro Kikkawa, Keita Sakashita, Shion Uemura, Yasunori Nishida, Takaya Kusumi, Shigeyuki Sasaki

Erschienen in: Surgery Today | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study investigated the diagnostic accuracy of hybrid positron-emission tomography/computed tomography (PET/CT) for lymph node (LN) metastasis of esophageal cancer. We also investigated the correlation between the size of metastatic nests and the detection by PET/CT.

Methods

Two hundred and fifty-eight patients with esophageal squamous cell carcinoma who underwent esophagectomy with two- or three-field radical lymphadenectomy were analyzed retrospectively. We compared the diagnosis of preoperative PET/CT to the postoperative histopathological examination by each anatomical field (n = 1,231) in all 258 patients. The metastatic LNs resected from PET/CT positive fields were classified as belonging to the PET/CT-N-positive group (n = 229) and those from negative fields as belonging to the PET/CT-N-negative group (n = 352). The cross-sectional areas of metastatic nests were measured in each metastatic LN.

Results

Of the 1,231 fields, 275 (22 %) were positive for metastasis, including 581 LNs from 408 regional LN stations. The sensitivity and specificity of PET/CT examined by each anatomical field were 25.8 and 97.8 %, respectively. The median area of metastatic nests was 17.7 mm2 in the PET/CT-N-positive group, and 7.7 mm2 in the PET/CT-N-negative group (p < 0.001).

Conclusions

A significant correlation was suggested between the nest size and detection by PET/CT. Because of its low sensitivity, PET/CT alone is insufficient to determine the surgical procedures, especially when considering reduction surgery.
Literatur
1.
Zurück zum Zitat Bollschweiler E, Baldus S, Schröder W, Prenzel K, Gutschow C, Schneider PM, et al. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy. 2006;38:149–56.PubMedCrossRef Bollschweiler E, Baldus S, Schröder W, Prenzel K, Gutschow C, Schneider PM, et al. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy. 2006;38:149–56.PubMedCrossRef
2.
3.
Zurück zum Zitat Altorki N, Kent M, Ferrara C, Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg. 2002;236:177–83.PubMedCentralPubMedCrossRef Altorki N, Kent M, Ferrara C, Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg. 2002;236:177–83.PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Kakeji Y, Yamamoto M, Ito S, Sugiyama M, Egashira A, Saeki H, et al. Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection. Surg Today. 2012;42(4):351–8.PubMedCrossRef Kakeji Y, Yamamoto M, Ito S, Sugiyama M, Egashira A, Saeki H, et al. Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection. Surg Today. 2012;42(4):351–8.PubMedCrossRef
5.
Zurück zum Zitat Kato H, Nakajima M. The efficacy of FDG-PET for the management of esophageal cancer: review article. Ann Thorac Cardiovasc Surg. 2012;18:412–9.PubMedCrossRef Kato H, Nakajima M. The efficacy of FDG-PET for the management of esophageal cancer: review article. Ann Thorac Cardiovasc Surg. 2012;18:412–9.PubMedCrossRef
6.
Zurück zum Zitat Kato H, Kimura H, Nakajima M, Sakai M, Sano A, Tanaka N, et al. The additional value of integrated PET/CT over PET in initial lymph node staging of esophageal cancer. Oncol Rep. 2008;20:857–62.PubMed Kato H, Kimura H, Nakajima M, Sakai M, Sano A, Tanaka N, et al. The additional value of integrated PET/CT over PET in initial lymph node staging of esophageal cancer. Oncol Rep. 2008;20:857–62.PubMed
7.
Zurück zum Zitat Yen T-J, Chung C-S, Wu Y-W, Yen R-F, Cheng M-F, Lee J-M, et al. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma. Dis Esophagus. 2012;25:40–7.PubMedCrossRef Yen T-J, Chung C-S, Wu Y-W, Yen R-F, Cheng M-F, Lee J-M, et al. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma. Dis Esophagus. 2012;25:40–7.PubMedCrossRef
8.
Zurück zum Zitat Itoh K, Hosokawa M, Fujita M. <18F>FDG-PET/CT in esophageal cancer: comparison between PET and histopathological evaluation on metastasis to locoregional lymph node. (in Japanese). Jpn J Clin Radiol. 2008;53:501–7. Itoh K, Hosokawa M, Fujita M. <18F>FDG-PET/CT in esophageal cancer: comparison between PET and histopathological evaluation on metastasis to locoregional lymph node. (in Japanese). Jpn J Clin Radiol. 2008;53:501–7.
9.
Zurück zum Zitat Han D, Yu J, Zhong X, Fu Z, Mu D, Zhang B, et al. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study. Dis Esophagus. 2012;25:416–26.PubMedCrossRef Han D, Yu J, Zhong X, Fu Z, Mu D, Zhang B, et al. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study. Dis Esophagus. 2012;25:416–26.PubMedCrossRef
10.
Zurück zum Zitat Tanabe S, Naomoto Y, Shirakawa Y, Fujiwara Y, Sakurama K, Noma K, et al. F-18 FDG PET/CT contributes to more accurate detection of lymph nodal metastasis from actively proliferating esophageal squamous cell carcinoma. Clin Nucl Med. 2011;36:854–9.PubMedCrossRef Tanabe S, Naomoto Y, Shirakawa Y, Fujiwara Y, Sakurama K, Noma K, et al. F-18 FDG PET/CT contributes to more accurate detection of lymph nodal metastasis from actively proliferating esophageal squamous cell carcinoma. Clin Nucl Med. 2011;36:854–9.PubMedCrossRef
12.
Zurück zum Zitat Yoon SK, Jung JI, Park MJ, Park HJ, Ahn MI, Park JG, et al. Multidetector CT assessment of lymph node size for nodal staging in patients with potentially operable squamous esophageal cancer and the 18F-FDG positron emission tomography CT correlation. J Korean Soc Radiol. 2010;62:235–43. Yoon SK, Jung JI, Park MJ, Park HJ, Ahn MI, Park JG, et al. Multidetector CT assessment of lymph node size for nodal staging in patients with potentially operable squamous esophageal cancer and the 18F-FDG positron emission tomography CT correlation. J Korean Soc Radiol. 2010;62:235–43.
13.
Zurück zum Zitat Okada M, Murakami T, Kumano S, Kuwabara M, Shimono T, Hosono M, et al. Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer. Ann Nucl Med. 2009;23:73–80.PubMedCrossRef Okada M, Murakami T, Kumano S, Kuwabara M, Shimono T, Hosono M, et al. Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer. Ann Nucl Med. 2009;23:73–80.PubMedCrossRef
14.
Zurück zum Zitat Itoh K, Hosokawa M, et al. Companion to F-18FDG PET/CT (in Japanese). Tokyo: Medical Review; 2012. Itoh K, Hosokawa M, et al. Companion to F-18FDG PET/CT (in Japanese). Tokyo: Medical Review; 2012.
15.
Zurück zum Zitat The Japan Esophageal Society. Japanese Classification of Esophageal Cancer. April 2008 (The 10th ed., Revised Version) (in Japanese) Tokyo: Kanehara; 2008. The Japan Esophageal Society. Japanese Classification of Esophageal Cancer. April 2008 (The 10th ed., Revised Version) (in Japanese) Tokyo: Kanehara; 2008.
16.
Zurück zum Zitat Natsugoe S, Mueller J, Stein H, Feith M, Höfler H, Siewert J. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: frequency, associated tumor characteristics, and impact on prognosis. Cancer. 1998;83:858–66.PubMedCrossRef Natsugoe S, Mueller J, Stein H, Feith M, Höfler H, Siewert J. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: frequency, associated tumor characteristics, and impact on prognosis. Cancer. 1998;83:858–66.PubMedCrossRef
17.
Zurück zum Zitat Greene FL, Page DL, Fleming ID, et al., editors. AJCC cancer staging manual. 6th ed. New York: Springer; 2002. Greene FL, Page DL, Fleming ID, et al., editors. AJCC cancer staging manual. 6th ed. New York: Springer; 2002.
18.
Zurück zum Zitat Sobin L, Wittekind C. International Union Against Cancer (UICC). TNM Classification of Malignant Tumors. 6th ed. New York: Wiley; 2002. Sobin L, Wittekind C. International Union Against Cancer (UICC). TNM Classification of Malignant Tumors. 6th ed. New York: Wiley; 2002.
19.
Zurück zum Zitat Kato H, Kuwano H, Nakajima M, Miyazaki T, Yoshikawa M, Ojima H, et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer. 2002;94:921–8.PubMedCrossRef Kato H, Kuwano H, Nakajima M, Miyazaki T, Yoshikawa M, Ojima H, et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer. 2002;94:921–8.PubMedCrossRef
20.
Zurück zum Zitat Pedersen P. Warburg, me and Hexokinase 2: multiple discoveries of key molecular events underlying one of cancers’ most common phenotypes, the ‘Warburg Effect’, i.e., elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr. 2007;39:211–22.PubMedCrossRef Pedersen P. Warburg, me and Hexokinase 2: multiple discoveries of key molecular events underlying one of cancers’ most common phenotypes, the ‘Warburg Effect’, i.e., elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr. 2007;39:211–22.PubMedCrossRef
21.
Zurück zum Zitat Haley M, Konski A, Li T, Jonathan DC, Maurer A, Haluszka O, et al. Influence of diabetes on the interpretation of PET scans in patients with esophageal cancer. GCR. 2009;3:149–52.PubMedCentralPubMed Haley M, Konski A, Li T, Jonathan DC, Maurer A, Haluszka O, et al. Influence of diabetes on the interpretation of PET scans in patients with esophageal cancer. GCR. 2009;3:149–52.PubMedCentralPubMed
22.
Zurück zum Zitat Gorenberg M, Hallett W, O’Doherty MJ. Does diabetes affect [18F]FDG standardized uptake values in lung cancer? Eur J Nucl Med. 2002;29:1324–7.CrossRef Gorenberg M, Hallett W, O’Doherty MJ. Does diabetes affect [18F]FDG standardized uptake values in lung cancer? Eur J Nucl Med. 2002;29:1324–7.CrossRef
23.
Zurück zum Zitat Torizuka T, Zasadny KR, Wahl RL. Diabetes decreases FDG accumulation in primary lung cancer. Clin Positron Imaging. 1999;2:281–7.PubMedCrossRef Torizuka T, Zasadny KR, Wahl RL. Diabetes decreases FDG accumulation in primary lung cancer. Clin Positron Imaging. 1999;2:281–7.PubMedCrossRef
24.
Zurück zum Zitat Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer—a PET study. J Nucl Med. 1993;34:1–6.PubMed Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer—a PET study. J Nucl Med. 1993;34:1–6.PubMed
25.
Zurück zum Zitat Yasuda T, Higuchi I, Yano M, Miyata H, Yamasaki M, Takiguchi S, et al. The impact of 18F-fluorodeoxyglucose positron emission tomography positive lymph nodes on postoperative recurrence and survival in resectable thoracic esophageal squamous cell carcinoma. Ann Surg Oncol. 2012;19:652–60.PubMedCrossRef Yasuda T, Higuchi I, Yano M, Miyata H, Yamasaki M, Takiguchi S, et al. The impact of 18F-fluorodeoxyglucose positron emission tomography positive lymph nodes on postoperative recurrence and survival in resectable thoracic esophageal squamous cell carcinoma. Ann Surg Oncol. 2012;19:652–60.PubMedCrossRef
26.
Zurück zum Zitat Strauss L. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med. 1996;23:1409–15.PubMedCrossRef Strauss L. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med. 1996;23:1409–15.PubMedCrossRef
27.
Zurück zum Zitat Hosokawa M, Nishida Y, Koide T. Middle thoracic esophageal cancer (in Japasese). Shujutsu (Jpn Operation). 2007;61:271–7. Hosokawa M, Nishida Y, Koide T. Middle thoracic esophageal cancer (in Japasese). Shujutsu (Jpn Operation). 2007;61:271–7.
28.
Zurück zum Zitat Mu DB, Wang SP, Yang WF, Fu Z, Chen XX, Sun XR, et al. Correlation between FDG PET/CT and the expression of glutI and ki-67 antigen in esophageal cancer (in Chinese). Zhonghua Zhong Liu Za Zhi. 2007;29:30–3.PubMed Mu DB, Wang SP, Yang WF, Fu Z, Chen XX, Sun XR, et al. Correlation between FDG PET/CT and the expression of glutI and ki-67 antigen in esophageal cancer (in Chinese). Zhonghua Zhong Liu Za Zhi. 2007;29:30–3.PubMed
Metadaten
Titel
Diagnostic value of 18F-FDG PET/CT for lymph node metastasis of esophageal squamous cell carcinoma
verfasst von
Hiroyuki Yamada
Masao Hosokawa
Kazuo Itoh
Toshinao Takenouchi
Yoshihiro Kinoshita
Tomohiro Kikkawa
Keita Sakashita
Shion Uemura
Yasunori Nishida
Takaya Kusumi
Shigeyuki Sasaki
Publikationsdatum
01.07.2014
Verlag
Springer Japan
Erschienen in
Surgery Today / Ausgabe 7/2014
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-013-0725-z

Weitere Artikel der Ausgabe 7/2014

Surgery Today 7/2014 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 24 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Metformin rückt in den Hintergrund

24.04.2024 DGIM 2024 Kongressbericht

Es hat sich über Jahrzehnte klinisch bewährt. Doch wo harte Endpunkte zählen, ist Metformin als alleinige Erstlinientherapie nicht mehr zeitgemäß.

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.